Trial
NCT04830982
Safety and Efficacy of IV Diazoxide as an Additive to Hyperkalemic Cardioplegia in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Johns Hopkins University
Collaborators
—
Condition
Myocardial Stunning
Intervention
IV Diazoxide
Why stopped
Withdrawn in IRB.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-09-19